EUVIMEDEUVIMED entdecken
Kohortenstudie

Cardiovascular outcomes of enzyme‐inducing anti‐seizure medications: A real‐world Asian cohort study

Chun-Yu Cheng iD, Ting-Chung Wang iD, Chia-Yu Hsu iD, Meng-Hung Lin iD, Chia-Yen Liu, Chih-Hao Chang iD

Epileptic Disorders · 30.09.2026

DOI: 10.1002/epd2.70430 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Epileptic Disorders, online erschienen am 30.09.2026. Verfasst von Chun-Yu Cheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Chang Gung Memorial Hospital, Chiayi, Taiwan. Die Arbeit nennt 22 Literaturangaben. Gefördert von: Chang Gung Medical Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine whether enzyme‐inducing anti‐seizure medications (EIASMs) are associated with differential risks of major adverse cardiovascular events (MACE) and all‐cause mortality compared with non‐enzyme‐inducing anti‐seizure medications (NEIASMs) in adults with epilepsy.

Methods

Using the Chang Gung Research Database (2010–2019), adults with epilepsy receiving at least 28 cumulative days of anti‐seizure medication therapy within 180 days of the index date were classified as EIASMs or NEIASMs users. Stabilized inverse probability of treatment weighting (IPTW) addressed confounding by indication. Composite MACE encompassing myocardial infarction (MI), arrhythmia, heart failure, ischemic stroke, hemorrhagic stroke, and sudden cardiac death and all‐cause mortality were co‐primary endpoints evaluated using Cox proportional hazards and Fine–Gray competing risk models.

Results

Of 20 693 eligible patients, 10 571 received EIASMs and 10 122 received NEIASMs. After IPTW, all covariates were balanced (absolute standardized mean differences

Schlagwörter

Stichwörter der Autor:innen

cardiovascular outcomesenzyme‐inducing anti‐seizure medicationsepilepsymajor adverse cardiovascular events

Autor:innen und Institutionen

  • Department of Neurosurgery, Chang Gung Memorial Hospital, Chiayi, Taiwan.
  • College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Department of Neurology, Chang Gung Memorial Hospital, Chiayi, Taiwan.
  • Health Information and Epidemiology Laboratory, Chang Gung Memorial Hospital, Chiayi, Taiwan.
  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Jen Ai Hospital, Taichung, Taiwan.
  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, New Taipei Municipal Tucheng Hospital, New Taipei City, Taiwan.

ORCID-Profile: Chun-Yu Cheng, Ting-Chung Wang, Chia-Yu Hsu, Meng-Hung Lin, Chih-Hao Chang

Förderung

  • Chang Gung Medical Foundation

Zitieren

APA

Cheng, C. Y., Wang, T. C., Hsu, C. Y., Lin, M. H., Liu, C. Y., & Chang, C. H. (2026). Cardiovascular outcomes of enzyme‐inducing anti‐seizure medications: A real‐world Asian cohort study. Epileptic Disorders. https://doi.org/10.1002/epd2.70430

Vancouver

Cheng CY, Wang TC, Hsu CY, Lin MH, Liu CY, Chang CH. Cardiovascular outcomes of enzyme‐inducing anti‐seizure medications: A real‐world Asian cohort study. Epileptic Disorders. 2026. doi:10.1002/epd2.70430

BibTeX
@article{Cheng2026,
  author = {Cheng, Chun-Yu and Wang, Ting-Chung and Hsu, Chia-Yu and Lin, Meng-Hung and Liu, Chia-Yen and Chang, Chih-Hao},
  title = {Cardiovascular outcomes of enzyme‐inducing anti‐seizure medications: A real‐world Asian cohort study},
  journal = {Epileptic Disorders},
  year = {2026},
  doi = {10.1002/epd2.70430}
}
Kostenlos starten →